Celularity Inc (CELU) Live Share Price, Invest From India

Celularity Inc Stock Performance

as on October 25, 2025 at 1:29 am IST

Day's Low
Day's High
$1.99
Day's Price Range
$2.1
$2.07
3.86%
Downside
1.45%
Upside
52 Week's Low
52 Week's High
$1
52-Week Price Range
$5.22
$2.07
51.66%
Downside
152.17%
Upside

Celularity Inc share price movements today

Previous Close: $1.99
Open: $2.02
Volume: 1.6M
Day's Low - High: $1.99 - $2.1
52 Week Low - High: $1 - $5.22

Celularity Inc Historical Returns

1 Month Return: + 1.47 %
3 Month Return: -30.07 %
1 Year Return: + 11.29 %
3 Year Return: -91 %
5 Year Return: 0 %

Celularity Inc Stock Fundamentals & Key Indicators

Check Celularity Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$53.1M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.61%

PE Ratio (TTM)

-0.33

Industry PE ratio

-2.8126038781163434

PEG Ratio

EBITDA

-39.9M

Revenue (TTM)

44.6M

Profit Margin

-165.21%

Return On Equity TTM

-6367.24%

Celularity Inc Stock Valuation

Track how Celularity Inc P/E has moved over time to understand its valuation trends.

Celularity Inc in the last 5 years

Overview
Trends

Lowest (-189.67x)

September 30, 2022

Industry (-2.81x)

October 25, 2025

Today (-0.33x)

October 25, 2025

Highest (-0.62x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.33x

Celularity Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Celularity Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Celularity Inc	BUY	$53.1M	NA	-0.33	-165.21%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	251.51%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$109.3B	99.16%	30.04	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$62.0B	-0.32%	14.51	31.37%

Stock Returns calculator for Celularity Inc Stock including INR - Dollar returns

The Celularity Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Celularity Inc investment value today

Current value as on today

₹1,15,897

Returns

₹15,897

(+15.9%)

Returns from Celularity Inc Stock

₹11,290 (+11.29%)

Dollar Returns*

₹4,606 (+4.61%)

Analyst Recommendation on Celularity Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Celularity Inc. Average target price of $2.5

Celularity Inc Share Price Target

Get share price movements and forecasts by analysts on Celularity Inc.

What analysts predicted

17.2%UPSIDE

Target Price

$2.5

Current Price

$2.07

Analyzed by

7 Analysts

Target

$2.50

Celularity Inc target price $2.5, a slight upside of 17.2% compared to current price of $2.07. According to 7 analysts rating.

Celularity Inc Stock’s Investor Sentiment and Interest

Search interest for Celularity Inc Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 26, 2025 to October 26, 2025

Change:-35% versus previous 30 day period

Celularity Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	2	3	3	14	12	9	18	18	5
Gross Profit	-21	2	0	0	13	2	5	10	10	0
Operating Income	-63	-42	-16	-99	-7	13	-11	-9	-9	-15
EBITDA	-61	-44	-	-90	-	-8	-12	-	-9	-20
Interest Expense	0	1	0	0	1	0	1	1	1	1
Depreciation	2	2	2	2	2	1	1	1	1	1
Income Before Tax	-64	-47	-93	-93	-22	9	-16	-13	-13	-24
Income Tax Expense	0	-3	-	2	-	0	-13	-	13	-
Net Income	-64	-47	-93	-93	-22	9	-16	-13	-13	-24
Net Profit Margin	-1626.86%	-1632.03%	-2479.56%	-2479.56%	-149.94%	78.82%	-173.17%	-73.31%	-73.31%	-427.55%

Celularity Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	17	21	14	21	17	22	54
Gross Profit	10	14	9	11	-1	6	39
Operating Income	0	0	-151	-109	-25	-76	-38
EBITDA	0	-1	-202	-88	23	-	-43
Interest Expense	-	3	2	3	3	3	6
Depreciation	-	-	8	8	9	9	7
Income Before Tax	0	6	-212	-100	14	-196	-57
Income Tax Expense	21	0	-4	0	0	-	0
Net Income	0	5	-208	-100	14	-196	-57
Net Profit Margin	-0.01%	27.80%	-1458.42%	-469.27%	78.95%	-862.04%	-106.77%

Celularity Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-47	-93	-93	-22	9	-16	-13	-13	-24
Operating Cash Flow	-11	-8	-8	-4	-4	0	1	1	0
Investing Cash Flow	0	-	0	-	0	0	-	-1	-
Financing Cash Flow	5	5	5	6	0	0	0	0	1
Change in Cash	-5	-2	-2	1	-4	0	0	0	0

Celularity Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-211	-208	-100	14	-196	-57
Operating Cash Flow	-1	-63	-110	-137	-38	-6
Investing Cash Flow	-286	-12	-5	-5	-	0
Financing Cash Flow	288	102	98	119	24	6
Change in Cash	0	26	-17	-23	-18	0

Global Institutional Holdings in Celularity Inc

Funds	Holdings
C V Starr & Co Inc	2.86%
Vanguard Group Inc	1.87%
Geode Capital Management, LLC	0.51%
BlackRock Inc	0.39%
State Street Corp	0.25%

See all

Insights on Celularity Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 51.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 130.5% return, outperforming this stock by 221.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -13.29M → -24.52M (in $), with an average decrease of 84.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 3 months, CELU stock has moved down by -30.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 18.13M → 5.73M (in $), with an average decrease of 68.4% per quarter

About Celularity Inc

Celularity, Inc. headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

Organisation	Celularity Inc
Headquarters	170 Park Avenue, Florham Park, NJ, United States, 07932
Industry	Healthcare
CEO	Dr. Robert Joseph Hariri M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Celularity Inc

Name	Title
Mr. John R. Haines	Senior EVP, Corporate Secretary, Global Manager & Chief Administrative Officer
Mr. Joseph C. DosSantos CPA, MBA	Senior VP of Finance & Interim CFO
Mr. Carlos Ramirez	SVP of Investor Relations
Dr. Stephen A. Brigido D.P.M.	President of Degenerative Diseases
Sharmila Koppisetti M.D.	Senior Vice President of Clinical Dev. Immunology & Drug Safety
Mr. Tim Wilk	Senior Vice President of Technical Operations
Mr. David Jakob Lemus CPA, M.S., MBA	Treasurer
Dr. Robert Joseph Hariri M.D., Ph.D.	Founder, CEO & Chairman

FAQs

What is Celularity Inc share price today?

Celularity Inc share price today is $2.07 as on October 25, 2025 at 1:29 am IST at the close of the market. Celularity Inc share today touched a day high of $2.1 and a low of $1.99.

What is the 52 week high and 52 week low for Celularity Inc share?

Celularity Inc share touched a 52 week high of $5.22 on November 7, 2024 and a 52 week low of $1 on March 4, 2025. Celularity Inc stock price today i.e. October 25, 2025 at 1:29 am IST is closed at $2.07,which is 60.34% down from its 52 week high and 106.86% up from its 52 week low.

What is Celularity Inc's market capitalisation today?

Celularity Inc market capitalisation is $0.00T as on October 25, 2025 at 1:29 am IST.

How to invest in Celularity Inc Stock (CELU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Celularity Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celularity Inc Shares that will get you 0.7246 shares as per Celularity Inc share price of $2.07 per share as on October 25, 2025 at 1:29 am IST.

What is the minimum amount required to buy Celularity Inc Stock (CELU) from India?

Indian investors can start investing in Celularity Inc (CELU) shares with as little as ₹87.796 or $1 (as of October 26, 2025 at 1:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Celularity Inc stock (as per the Rupee-Dollar exchange rate as on October 26, 2025 at 1:42 pm IST). Based on Celularity Inc share’s latest price of $2.07 as on October 25, 2025 at 1:29 am IST, you will get 4.8309 shares of Celularity Inc. Learn more about fractional shares .